Search
cbdMD Inc
YCBDAdd to Watchlist
0.471USD
-0.029-5.80%
Market hours 09/18, 13:09（ET）
5.24MMarket Cap
0.02P/E TTM
cbdMD Inc (YCBD) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to cbdMD Inc in the past month.
Hold
0 Strong Buy
0 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
2.000USD+303.47%
YCBD Analyst Recommendation Trends
In the current month, YCBD has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. YCBD average Analyst price target in the last month is 2.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
YCBD Analyst Rating for Peer Comparison
Updated: Sep 17, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, YCBD EPS is projected to reach -0.090 in FY2026Q4, following reported EPS of -0.113 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.06
-0.05
-0.03
-0.09
-0.06
Actual
-0.04
-0.08
-0.11
--
--
Surprise
+39.92%
-67.90%
-276.20%
--
--
FAQs
What is cbdMD Inc's expected revenue for the next quarter?
cbdMD Inc's expected revenue is 5.71M.
What is cbdMD Inc's price target?
Analysts forecast that cbdMD Inc's price target is USD 2.00, with the highest forecast at USD 2.00 and the lowest forecast at USD 2.00.
How have cbdMD IncYCBD's recent earnings per share performed?
The market expectation was USD -0.11, while cbdMD IncYCBD's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for cbdMD Inc?
Based on the ratings of cbdMD Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.